Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1989 1
1990 2
1992 2
1993 2
1994 1
1999 1
2000 1
2002 1
2005 1
2006 1
2008 3
2009 1
2010 4
2011 1
2012 2
2013 1
2014 1
2015 2
2016 2
2017 2
2019 1
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Dilated cardiomyopathy 2A"
Page 1
Triptófano-5-hidroxilasa, transportador de serotonina y receptores serotoninérgicos en miocardiopatía dilatada.
Mondragón-Herrera JA, Serrano-Hernández Y, Valero-Elizondo G, Mansilla-Olivares A, Manjarrez-Gutiérrez G. Mondragón-Herrera JA, et al. Cir Cir. 2022;90(6):781-788. doi: 10.24875/CIRU.21000506. Cir Cir. 2022. PMID: 36472833 Free article. English.
OBJECTIVE: To determine the expression of tryptophan-5-hydroxylase (TPH) 1 and 2, serotonin transporter protein (SERT) and serotonergic receptors in hearts with dilated cardiomyopathy (DCM) compared to controls. METHOD: A comparative study was performed in six tissu …
OBJECTIVE: To determine the expression of tryptophan-5-hydroxylase (TPH) 1 and 2, serotonin transporter protein (SERT) and serotonergic rece …
Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
Xu J, Gong NL, Bodi I, Aronow BJ, Backx PH, Molkentin JD. Xu J, et al. J Biol Chem. 2006 Apr 7;281(14):9152-62. doi: 10.1074/jbc.M510217200. Epub 2006 Feb 9. J Biol Chem. 2006. PMID: 16469744 Free article.
Here we demonstrate that MEF2 transcription factors induced dilated cardiomyopathy and lengthening of myocytes. Specifically, multiple transgenic mouse lines with cardiac-specific overexpression of MEF2A or MEF2C presented with cardiomyopathy at base line or …
Here we demonstrate that MEF2 transcription factors induced dilated cardiomyopathy and lengthening of myocytes. Specifically, …
Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy.
Feldtmann R, Kümmel A, Chamling B, Strohbach A, Lehnert K, Gross S, Loerzer L, Riad A, Lindner D, Westermann D, Fielitz J, Dörr M, Felix SB. Feldtmann R, et al. Immunology. 2022 Sep;167(1):40-53. doi: 10.1111/imm.13490. Epub 2022 Jun 29. Immunology. 2022. PMID: 35502635 Free article.
Plasma levels of myeloid differentiation factor-2 (MD-2), a co-receptor of toll-like-receptor 4 (TLR4), independently predict mortality in patients with dilated cardiomyopathy (DCM). We tested whether monocyte activation by MD-2 contributes to immune activati …
Plasma levels of myeloid differentiation factor-2 (MD-2), a co-receptor of toll-like-receptor 4 (TLR4), independently predict mortali …
Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions.
Bouin A, Vu MN, Al-Hakeem A, Tran GP, Nguyen JHC, Semler BL. Bouin A, et al. J Virol. 2023 Jan 31;97(1):e0142622. doi: 10.1128/jvi.01426-22. Epub 2022 Dec 8. J Virol. 2023. PMID: 36475766 Free PMC article.
Group B enteroviruses, including coxsackievirus B3 (CVB3), can persistently infect cardiac tissue and cause dilated cardiomyopathy. Persistence is linked to 5' terminal deletions of viral genomic RNAs that have been detected together with minor populations of full-l …
Group B enteroviruses, including coxsackievirus B3 (CVB3), can persistently infect cardiac tissue and cause dilated cardiomyopathy …
Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy.
Henry TD, Traverse JH, Hammon BL, East CA, Bruckner B, Remmers AE, Recker D, Bull DA, Patel AN. Henry TD, et al. Circ Res. 2014 Sep 26;115(8):730-7. doi: 10.1161/CIRCRESAHA.115.304554. Epub 2014 Aug 20. Circ Res. 2014. PMID: 25142002 Clinical Trial.
OBJECTIVE: To evaluate the safety and efficacy of ixmyelocel-T in 2 prospective randomized phase 2A Trials administered via minithoracotomy or intramyocardial catheter injections in patients with dilated cardiomyopathy (DCM) stratified by ischemic or nonische …
OBJECTIVE: To evaluate the safety and efficacy of ixmyelocel-T in 2 prospective randomized phase 2A Trials administered via minithora …
Insulin-like growth factor binding protein 2: a core biomarker of left ventricular dysfunction in dilated cardiomyopathy.
Yu W, Gao H, Hu T, Tan X, Liu Y, Liu H, He S, Chen Z, Guo S, Huang J. Yu W, et al. Hereditas. 2023 Oct 31;160(1):36. doi: 10.1186/s41065-023-00298-5. Hereditas. 2023. PMID: 37904201 Free PMC article.
BACKGROUND: RNA modifications, especially N6-methyladenosine, N1-methyladenosine and 5-methylcytosine, play an important role in the progression of cardiovascular disease. However, its regulatory function in dilated cardiomyopathy (DCM) remains to be undefined. METH …
BACKGROUND: RNA modifications, especially N6-methyladenosine, N1-methyladenosine and 5-methylcytosine, play an important role in the progres …
Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV in Cardiomyocytes.
Alvarez MS, Núñez E, Fuertes-Agudo M, Cucarella C, Fernandez-Velasco M, Boscá L, Vázquez J, Rossignol R, Martin-Sanz P, Casado M. Alvarez MS, et al. Int J Mol Sci. 2022 Nov 3;23(21):13476. doi: 10.3390/ijms232113476. Int J Mol Sci. 2022. PMID: 36362254 Free PMC article.
Cyclooxygenase 2 (COX-2), a key enzyme in prostanoid synthesis, is expressed in human ischemic myocardium and dilated cardiomyopathy, but it is absent in healthy hearts. To assess the role of COX-2 in cardiovascular physiopathology, we developed transgenic mice that …
Cyclooxygenase 2 (COX-2), a key enzyme in prostanoid synthesis, is expressed in human ischemic myocardium and dilated cardiomyopat …
Predicting cardiomyopathic phenotypes by altering Ca2+ affinity of cardiac troponin C.
Parvatiyar MS, Pinto JR, Liang J, Potter JD. Parvatiyar MS, et al. J Biol Chem. 2010 Sep 3;285(36):27785-97. doi: 10.1074/jbc.M110.112326. Epub 2010 Jun 21. J Biol Chem. 2010. PMID: 20566645 Free PMC article.
Cardiac diseases associated with mutations in troponin subunits include hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM). ...
Cardiac diseases associated with mutations in troponin subunits include hypertrophic cardiomyopathy (HCM), dilated cardiomy …
Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT.
Miller WL, Behrenbeck TR, McCollough CH, Williamson EE, Leng S, Kline TL, Ritman EL. Miller WL, et al. Int J Cardiovasc Imaging. 2015 Apr;31(4):881-8. doi: 10.1007/s10554-015-0619-9. Epub 2015 Feb 25. Int J Cardiovasc Imaging. 2015. PMID: 25712168 Free PMC article.
Our goal was to determine whether the spatial analysis of perfusion CT could clinically detect changes in the function and structure of the intramyocardial microcirculation in a non-ischemic dilated cardiomyopathy (DCM). Two groups were studied: (1) a Control group …
Our goal was to determine whether the spatial analysis of perfusion CT could clinically detect changes in the function and structure of the …
Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease.
Hare JM, Walford GD, Hruban RH, Hutchins GM, Deckers JW, Baughman KL. Hare JM, et al. J Am Coll Cardiol. 1992 Nov 15;20(6):1318-25. doi: 10.1016/0735-1097(92)90243-g. J Am Coll Cardiol. 1992. PMID: 1430681 Free article.
OBJECTIVES: This study was designed to define clinical and pathophysiologic similarities and differences between patients with ischemic and idiopathic dilated cardiomyopathy. BACKGROUND: Significant coronary artery disease in patients with new onset congestive heart …
OBJECTIVES: This study was designed to define clinical and pathophysiologic similarities and differences between patients with ischemic and …
40 results